Cooper Companies COO
Nasdaq · Ophthalmic Goods · $11.8BData provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
2 stories have a settled next close so far (2 on the Wire). The record starts speaking at three.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via DatabentoOperating leverage — margins
| Line Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY Δ | 4Y CAGR | Trend |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $2.9B | $3.3B | $3.6B | $3.9B | $4.1B | +5.1% | +8.8% | |
| Cost of Revenue (COGS) | $966.7M | $1.2B | $1.2B | $1.3B | $1.4B | +8.5% | +9.9% | |
| Gross Profit | $2.0B | $2.1B | $2.4B | $2.6B | $2.7B | +3.3% | +8.2% | |
| Research & Development (R&D) | $92.7M | $110.3M | $137.4M | $155.1M | $172.2M | +11.0% | +16.7% | |
| Selling, General & Admin (SG&A) | $1.2B | $1.3B | $1.5B | $1.5B | $1.6B | +6.1% | +7.7% | |
| Total Operating Expenses | $1.4B | $1.6B | $1.8B | $1.9B | $2.0B | +5.8% | +8.4% | |
| Operating Income (EBIT) | $505.8M | $507.6M | $533.1M | $705.7M | $682.9M | −3.2% | +7.8% | |
| Interest Expense | $23.1M | $57.3M | $105.3M | $114.3M | $100.0M | −12.5% | +44.2% | |
| Income Tax Expense | $-2.5B | $89.5M | $118.7M | $190.0M | $191.6M | +0.8% | — | |
| GAAP Net Income | $2.9B | $385.8M | $294.2M | $392.3M | $374.9M | −4.4% | −40.3% | |
| Diluted EPS | $59.16 | $1.94 | $1.48 | $1.96 | $1.87 | −4.6% | −57.8% | |
| Diluted Shares | 49.8M | 198.8M | 199.3M | 200.4M | 200.0M | −0.2% | +41.6% | |
| Balance Sheet | ||||||||
| Cash & Equivalents | $96.6M | $138.6M | $120.9M | $107.7M | $110.6M | +2.7% | +3.4% | |
| Inventory | $585.6M | $628.7M | $735.6M | $802.7M | $846.0M | +5.4% | +9.6% | |
| Total Current Assets | $1.5B | $1.5B | $1.7B | $2.0B | $2.1B | +7.9% | +9.5% | |
| Total Assets | $9.6B | $11.5B | $11.7B | $12.3B | $12.4B | +0.6% | +6.6% | |
| Total Current Liabilities | $732.1M | $1.3B | $969.0M | $1.0B | $1.1B | +8.8% | +11.0% | |
| Total Debt (Short + Long Term) | $1.5B | $2.8B | $2.6B | $2.6B | $2.5B | −3.0% | +14.1% | |
| Total Liabilities | $2.7B | $4.3B | $4.1B | $4.2B | $4.2B | −1.8% | +11.8% | |
| Stockholders' Equity | $6.9B | $7.2B | $7.6B | $8.1B | $8.2B | +1.9% | +4.4% | |
| Net Cash / (Net Debt) | $-1.4B | $-2.6B | $-2.4B | $-2.5B | $-2.4B | +3.3% | — | |
| Invested Capital | $8.3B | $9.8B | $10.0B | $10.6B | $10.6B | +0.7% | +6.3% | |
| Cash Flow & Capital Allocation | ||||||||
| Operating Cash Flow (OCF) | $738.6M | $692.4M | $607.5M | $709.3M | $796.1M | +12.2% | +1.9% | |
| Depreciation & Amortization (D&A) | $309.3M | $346.1M | $367.7M | $375.1M | $377.4M | +0.6% | +5.1% | |
| Stock-Based Compensation (SBC) | $43.8M | $54.2M | $62.1M | $75.1M | $70.5M | −6.1% | +12.6% | |
| Capital Expenditures (CapEx) | $214.4M | $242.0M | $392.5M | $421.2M | $362.4M | −14.0% | +14.0% | |
| Free Cash Flow (FCF) | $524.2M | $450.4M | $215.0M | $288.1M | $433.7M | +50.5% | −4.6% | |
| True FCF (ex-SBC Owner Cash) | $480.4M | $396.2M | $152.9M | $213.0M | $363.2M | +70.5% | −6.8% | |
| Share Repurchases (Buybacks) | $24.8M | $78.5M | $0 | $0 | $290.1M | — | +84.9% | |
| Dividends Paid | $3.0M | $3.0M | $3.0M | $0 | $0 | — | — | |
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.